Mannathoko N, Mosepele M, Gross R, Smith R, Alby K, Glaser L,Richard-Greenblatt M, Sharma A,Jaskowiak-Barr A, Cressman L, Sewawa K, Cowden L, Reesey E, Otukile D, Paganotti G, Mokomane M, Lautenbach E : Colonization with Extended-Spectrum Cephalosporin-Resistant Enterobacterales (ESCrE) and Carbapenem-Resistant Enterobacterales (CRE) in Healthcare and Community Settings in Botswana: An Antibiotic Resistance in Communities and Hospitals (ARCH) Study
International Journal of Infectious Diseases 2022 (in press).
Martei YM, Narasimhamurthy M, Setlhako DI, Ayane G, Ralefala T, Chiyapo S, Gross R, Shulman LN, Grover S, DeMichele A : Relative Dose Intensity and Pathologic Response Rates in Breast Cancer Patients with and without HIV Who Received Neoadjuvant Chemotherapy
JCO Global Oncology 2022 (in press).
Sanchez AL, Hoskins K, Pettit AR, Momplaisir F, Gross R, Brady KA, Hoffacker C, Zentgraf K, Beidas RS: Stakeholder Perspectives on Implementing an Evidence-Based Behavioral Intervention for People with HIV: A Rapid Qualitative Analysis of Implementation Determinants
JAIDS 2022 (in press).
Motlokwa PK, Tsima BM, Martei YM, Ralefala T, Galebole F, Stephens-Shields AJ, Grover S,* Gross R*
* equal contribution by authors
: Disparities in Oral Cancer Stage at Presentation in a High HIV Prevalence Setting in Sub-Saharan Africa
JCO Global Oncology 2022 (in press).
Avihingsanon A, Hughes MD, Salata R, Godfrey C, McCarthy C, Mugyenyi P, Hogg E, Gross R, Cardoso SW, Bukuru A, Makanga M, Badal-Faesen S, Mave V, Wangari Ndege B, Nerette Fontain S, Samaneka W, Secours R, Van Schalkwyk M, Mngqibisa R, Mohapi L, Valencia J, Sugandhavesa P, Montalban E, Munyanga C, Chagomerana M, Santos BR, Kumarasamy N, Kanyama C, Schooley RT, Mellors JW, Wallis CL, Collier AC, Grinsztejn B for the A5288 Study team: Third-line antiretroviral therapy including raltegravir (RAL), darunavir (DRV/r) and/or etravirine (ETR) is well tolerated and achieves durable virologic suppression over 144+ weeks in resource limited settings: ACTG A5288 strategy trial. Journal of the International AIDS Society 2022 (in press).
O'Brien TC, Feinberg J, Gross R, Albarracin D: Supportive environments during the substance use disorder epidemic in the rural United States: Provider support for interventions and expectations of interactions with providers. Social Science & Medicine 2022 (in press).
Schnoll R, Bernstein SL, Kaufman A, Gross R, Catz S, Cioe P, Hitsman R, Marhefka SL, Pacek L, Vidrine D, Vilardaga R, Edelman EJ, McClure J, Ashare R, Lockhart E, Crothers K: COVID-19 challenges confronted by smoking cessation clinical trials for people living with HIV: The experience of grantees of the United States National Cancer Institute. Nicotine and Tobacco Research 2021 (in press).
Bien-Gund C, Shah J, Ho J, Shea K, Dugosh K, Gross R: The COVID-19 Self-Testing through Rapid Network Distribution (C-STRAND) trial: A randomized controlled trial to increase COVID-19 testing in underserved populations Contemporary Clinical Trials 2021 (in press).
Lowenthal ED, Ohrenshall R, Moshashane N, Bula B, Chapman J, Marukutira TC, Tshume O, Gross R, Mphele S.
: Reasons for Discordance between Antiretroviral Adherence Measures in Adolescents. AIDS Care 2021 (in press).
Mantshonyane L, Roy J, Levy MZ, Wallis CL, Bar K, Godfrey C, Collier A, LaRosa A, Zheng L, Sun X, Gross R: Participants switching to second-line antiretroviral therapy with susceptible virus display inferior adherence and worse outcomes: an observational analysis of prospectively collected data
AIDS Patient Care and STDs 2021 (in press).
back to top
Last updated: 06/03/2022
The Trustees of the University of Pennsylvania